CN Patent

CN105769755A — 一种溴甲纳曲酮注射液及其制备方法

Assigned to Peking University Founder Group Co Ltd · Expires 2016-07-20 · 10y expired

What this patent protects

本发明提供一种溴甲纳曲酮注射液，包括溴甲纳曲酮原料药和适量辅料。本发明还提供所述溴甲纳曲酮注射液的制备方法。本发明注射液高度稳定，即使在光照高温等情况下也基本稳定。

USPTO Abstract

本发明提供一种溴甲纳曲酮注射液，包括溴甲纳曲酮原料药和适量辅料。本发明还提供所述溴甲纳曲酮注射液的制备方法。本发明注射液高度稳定，即使在光照高温等情况下也基本稳定。

Drugs covered by this patent

methylnaltrexone-bromide (METHYLNALTREXONE BROMIDE)

Patent Metadata

Patent number: CN105769755A
Jurisdiction: CN
Classification: —
Expires: 2016-07-20
Drug substance claim: No
Drug product claim: No
Assignee: Peking University Founder Group Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.